Trial · NCT02265952
Adverse events124
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 124
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 1 | 9 | 1 |
| other | Anaemia | Blood and lymphatic system disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 1 | 8 | 1 |
| other | Corneal opacity | Eye disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 1 | 9 | 1 |
| other | Corneal opacity | Eye disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 0 | 8 | 0 |
| other | Eye inflammation | Eye disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 0 | 9 | 0 |
| other | Eye inflammation | Eye disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 1 | 8 | 1 |
| other | Abdominal pain | Gastrointestinal disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 0 | 9 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 1 | 8 | 2 |
| other | Diarrhoea | Gastrointestinal disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 1 | 9 | 2 |
| other | Diarrhoea | Gastrointestinal disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 4 | 8 | 6 |
| other | Faeces discoloured | Gastrointestinal disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 1 | 9 | 1 |
| other | Faeces discoloured | Gastrointestinal disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 0 | 8 | 0 |
| other | Nausea | Gastrointestinal disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 4 | 9 | 6 |
| other | Nausea | Gastrointestinal disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 3 | 8 | 5 |
| other | Vomiting | Gastrointestinal disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 1 | 9 | 1 |
| other | Vomiting | Gastrointestinal disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 1 | 8 | 1 |
| other | Chest discomfort | General disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 1 | 9 | 1 |
| other | Chest discomfort | General disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 1 | 8 | 1 |
| other | Chest pain | General disorders | Main Study Period: REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | 1 | 9 | 1 |
| other | Chest pain | General disorders | OLE Period: REGN1500 300 mg SC/20 mg/kg IV | 0 | 8 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02265952/events